Skip to main content

Table 1 Characteristic of axSpA patients and healthy blood donor groups

From: Sera of patients with axial spondyloarthritis (axSpA) enhance osteoclastogenic potential of monocytes isolated from healthy individuals

  axSpA patients Healthy subjects Pvalue
n, (%) 27 (56.25) 23 (43.75)  
Age, mean ± SD years 32.9 (7.7) 35.1 (5.4) 0.31
Sex, % male 59.5 52.4 0.61
HLA B27 positive, % 91.7 N/A  
Duration of symptoms, median (p25-p75) years 7.5 (5–10) N/A  
IBP, % 88.5 N/A  
CRP, median (p25-p75) mg/l 8.8 (2.4–12.9) 0.27 (0.18–0.54)a) < 0.0001
ESR, median (p25-p75) mm/h 22.5 (15.0–31.0) N/A  
BASDAI (0–10 scale), median (p25-p75) 2.1 (0.8–4.4) N/A  
ASDAS-CRP median (p25-p75) 2.1 (1.6–3.1) N/A  
mNY x-ray criteria for AS (%) 66.7 N/A  
mSASSS median (p25-p75) 3 (0–72) N/A  
  1. IBP inflammatory back pain, CRP C-reactive protein, ESR erythrocyte sedimentation rate, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, ASDAS Ankylosing Spondylitis Disease Activity Score, mNY modified New York, mSASSS modified Stokes Ankylosing Spondylitis Spinal Score
  2. a)data obtained from randomly chosen 9 healthy blood donors